BioXcel Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 1.03 M | $2.63 M | 100.00% | 13.11% |
| OAKTREE CAPITAL MANAGEMENT LP | 11/13/2025 | 241.19 K | $617.44 K | 0.00% | 3.08% |
| FMR LLC | 11/13/2025 | 198.60 K | $508.42 K | 100.00% | 2.53% |
| VANGUARD GROUP INC | 11/07/2025 | 192.13 K | $491.84 K | 920.64% | 2.45% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 125.24 K | $320.62 K | 344.40% | 1.60% |
| XTX TOPCO LTD | 11/14/2025 | 113.36 K | $290.21 K | 383.97% | 1.45% |
| BLACKROCK, INC. | 11/12/2025 | 84.28 K | $215.76 K | 374.08% | 1.07% |
| STATE STREET CORP | 11/14/2025 | 52.72 K | $134.96 K | 100.00% | 0.67% |
| UBS GROUP AG | 11/13/2025 | 43.54 K | $111.47 K | 9.18% | 0.56% |
| OAKTREE FUND ADVISORS, LLC | 11/14/2025 | 42.91 K | $109.86 K | 0.00% | 0.55% |
| NORTHERN TRUST CORP | 11/14/2025 | 37.73 K | $96.60 K | 100.00% | 0.48% |
| JONES FINANCIAL COMPANIES LLLP | 11/04/2025 | 36.00 K | $97.20 K | 38.46% | 0.46% |
| HIGHTOWER ADVISORS, LLC | 11/07/2025 | 35.00 K | $89.60 K | 42.28% | 0.45% |
| FOUNDATIONS INVESTMENT ADVISORS, LLC | 11/03/2025 | 29.55 K | $75.65 K | 100.00% | 0.38% |
| SLT HOLDINGS LLC | 10/23/2025 | 29.50 K | $75.52 K | 100.00% | 0.38% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 16.32 K | $41.77 K | -3.56% | 0.21% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 15.08 K | $61.07 K | 198.50% | 0.19% |
| DIVERSIFY WEALTH MANAGEMENT, LLC | 11/12/2025 | 15.00 K | $28.50 K | 0.00% | 0.19% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 6.88 K | $17.62 K | 344.80% | 0.09% |
| IFP ADVISORS, INC | 12/02/2025 | 4.37 K | $11.19 K | 100.00% | 0.06% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 3.93 K | $10.07 K | 187.08% | 0.05% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 2.25 K | $5.76 K | 76.67% | 0.03% |
| MORGAN STANLEY | 11/14/2025 | 1.64 K | $4.20 K | 3.86% | 0.02% |
| NEWEDGE ADVISORS, LLC | 11/17/2025 | 1.33 K | $3.41 K | 4,193.55% | 0.02% |
| CITIGROUP INC | 11/10/2025 | 355 | $909 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 169 | $433 | -80.77% | 0.00% |
| WASHINGTON TRUST ADVISORS, INC. | 11/10/2025 | 160 | $410 | 0.00% | 0.00% |
| PARKSIDE FINANCIAL BANK & TRUST | 10/30/2025 | 112 | $287 | 0.00% | 0.00% |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 11/14/2025 | 103 | $264 | 0.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 11/10/2025 | 60 | $154 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 45 | $115 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 39 | $100 | -11.36% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 11/14/2025 | 21 | $54 | 0.00% | 0.00% |
| US BANCORP \DE\ | 11/12/2025 | 1 | $3 | 0.00% | 0.00% |
| TRIUMPH CAPITAL MANAGEMENT | 11/17/2025 | 1 | $3 | 100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| BEACON POINTE ADVISORS, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| MOUNT YALE INVESTMENT ADVISORS, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| MURCHINSON LTD. | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BioXcel Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 53 institutional investors and hedge funds held shares of BioXcel Therapeutics, Inc.. The most heavily invested institutionals were:
MILLENNIUM MANAGEMENT LLC: 1.03 M
OAKTREE CAPITAL MANAGEMENT LP: 241,188
FMR LLC: 198,600
VANGUARD GROUP INC: 192,125
GEODE CAPITAL MANAGEMENT, LLC: 125,240
XTX Topco Ltd: 113,364
30.06% of BioXcel Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.81 M shares in the last 24 months. This purchase volume represents approximately $7.10 M in transactions.